On 22 November 2017, IRRAS started trading on Nasdaq First North Premier. IRRAS is a commercial stage medical technology company focused on designing, developing and commercializing innovative solutions for various brain pathologies.
After the offering, when trading started, the market value of IRRAS amounted to approximately SEK 1.1 billion.
ABG Sundal Collier AB was Sole Global Coordinator and Vator Securities AB was Financial Advisor. Baker McKenzie was legal advisor to the Sole Global Coordinator and Vator Securities AB as to Swedish and US law. The lawyers mainly involved from Baker McKenzie were Joakim Falkner, Stefan Balazs and Henric Roth from Stockholm and Adam Farlow and Roger James from the firm’s London office.